Sector valuations Capricor Therapeutics, Inc.
Equities
CAPR
US14070B3096
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.45 USD | +3.52% |
|
-4.81% | +10.50% |
| Apr. 22 | Capricor Therapeutics Announces Late-Breaking Presentation of Hope-3 Phase 3 Results | CI |
| Apr. 02 | Capricor Therapeutics Insider Sold Shares Worth $3,515,468, According to a Recent SEC Filing | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -77.65x | - | 0.94x | - | - | - | - | 1.76B | |
| 27.67x | 5.45x | 0.6x | 7.31x | 21.83x | 22.41x | -.--% | 49.1B | |
| 17.68x | 3.41x | -2.05x | 5.41x | 11.83x | 13.64x | 1.68% | 47.65B | |
| -18.13x | 1.06x | 2.96x | 3.57x | -6.5x | -5.02x | -.--% | 23.8B | |
| -37.65x | 58.75x | 0.65x | 12.57x | -34.1x | -39.81x | -.--% | 21.97B | |
| 21.42x | 2.11x | 1.51x | 4.23x | 10.98x | 13.21x | -.--% | 17.26B | |
| 23.19x | 2.43x | -0.86x | 4.36x | 13.78x | 16.16x | -.--% | 15.88B | |
| 835.27x | 12.1x | -7.5x | 19.71x | 107.94x | 226.47x | -.--% | 15.77B | |
| -15.16x | 68.75x | 0.84x | 3987.56x | -18.51x | -15.84x | -.--% | 14.03B | |
| -450.97x | 18.43x | 9.5x | 32.38x | -2027.81x | -318.72x | -.--% | 13.32B | |
| 15.25x | 4.32x | 1.12x | 4.37x | 10.24x | 11.27x | -.--% | 12.11B | |
| -76.98x | 26.16x | 1.59x | 7.51x | -70.78x | -55.08x | -.--% | 11.76B | |
| -23.72x | 20x | -0x | 19.7x | -27.51x | -21.61x | -.--% | 10.24B | |
| -11.83x | -11x | 18.95x | 94.56x | -12.55x | -12.24x | -.--% | 9.57B | |
| 13.27x | 6.66x | 0.03x | 8.1x | 13.37x | 12.36x | -.--% | 9.03B | |
| 31.95x | 5.22x | -2.55x | 7.21x | 28.04x | 31.99x | - | 9.03B | |
| -10.19x | - | -0.09x | - | - | - | - | 8.91B | |
| 36.16x | 6.88x | 0.76x | 10.48x | 26.59x | 27.37x | 0.23% | 8.58B | |
| -18.51x | 8.19x | 6.67x | 656.94x | -18.55x | -17.1x | -.--% | 8.32B | |
| Average | 14.79x | 14.05x | 1.74x | 287.41x | -115.98x | -6.50x | 0.12% | 16.21B | |
| Weighted average by Cap. | 25.61x | 13.17x | 0.98x | 217.75x | -84.37x | -0.04x | 0.29% |
- Stock Market
- Equities
- CAPR Stock
- Sector Capricor Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
